Rockwell Medical, Inc. (RMTI)

2.0600 +0.1200 (+6.19%) As of 02:42PM EDT. Market open.

Rockwell Medical, Inc.

30142 South Wixom road
Suite 501
Wixom, MI 48393
United States
248 960 9009
https://www.rockwellmed.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 300

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Russell L. Skibsted M.B.A.	Exec. VP, CFO & Chief Bus. Officer	598.92k	N/A	1959
Dr. Mark Strobeck Ph.D.	Pres, CEO & Director	N/A	N/A	1971
Mr. Michael DeYoung	VP of Operations	N/A	N/A	N/A
Mr. Paul E. McGarry	VP, Corp. Controller & Principal Accounting Officer	N/A	N/A	1968
Ms. Megan C. Timmins	Sr. VP, Gen. Counsel & Corp. Sec.	N/A	N/A	1973
Mr. James A. McCarthy	Sr. VP of Bus. & Corp. Devel.	N/A	N/A	N/A
Mr. Timothy T. Chole	Sr. VP of Sales & Marketing	N/A	N/A	N/A
Dr. Marc L. Hoffman	Chief Medical Officer	N/A	N/A	1961
Mr. David J. Kull	Sec.	N/A	N/A	1968
Mr. Jason Finkelstein	Investor Relations Representative	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Corporate Governance

Rockwell Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.